Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCropper (J) Regulatory News (CRPR)

Share Price Information for Cropper (J) (CRPR)

Share Price is delayed by 15 minutes
Get Live Data
365.00    20.00 (5.80%)
Bid:
350.00
Ask:
380.00
Spread: 30.00 (8.571%)
Market Cap: £34.88m
CRPR Live PriceLast checked at - London Stock Exchange

Intraday Cropper (J) Share Chart

Trading Statement

24 Apr 2009 07:00

RNS Number : 0877R
Cropper(James) PLC
24 April 2009
 

James Cropper PLC

Trading Update - Year ended 28 March 2009

STATEMENT BY THE CHAIRMAN, J A CROPPER

I am pleased to report that in the second half of the financial year Technical Fibre Products Limited traded strongly and that James Cropper Speciality Papers Limited made significant progress in reducing its first half losses. In addition, the full year IFRS pension adjustment charge relating to the Group's defined benefit pension schemes was less than anticipated. 

Therefore, although audit clearance is yet to be given, it should be anticipated that barring any unforeseen circumstances, the Group Profit before Tax for the year to 28 March 2009 will not be less than £0.7 million. This result would be above current market expectation.

The Group's Preliminary Results for the year to 28 March 2009 will be announced on Tuesday 23 June 2009.

Enquiries:

John Denman

Group Finance Director

Andrew Kitchingman

Managing Director, Corporate Finance

James Cropper PLC

Brewin Dolphin Investment Banking

Tel: 01539 722002 

Tel: 0845 270 8610

www.cropper.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTQXLFLKZBEBBD
Date   Source Headline
9th Nov 20217:00 amRNSDirectorate Change
9th Nov 20217:00 amRNSHalf-year Report
4th Nov 20217:00 amRNSDirectorate Change
24th Sep 20211:44 pmRNSDirector/PDMR Shareholding
9th Sep 20215:35 pmRNSDirector/PDMR Shareholding
12th Aug 20217:00 amRNSGrant of Awards under Long Term Incentive Plan
5th Aug 20217:00 amRNSDirector/PDMR Shareholding
4th Aug 20217:00 amRNSDirector/PDMR Shareholding
28th Jul 202111:00 amRNSAGM Statement and Trading Update
27th Jul 202110:27 amRNSDirector/PDMR Shareholding
23rd Jul 20219:52 amRNSDirector/PDMR Shareholding
23rd Jul 20217:00 amRNSUpdate for visitors to the AGM
21st Jul 20217:00 amRNSDirector/PDMR Shareholding
6th Jul 20217:46 amRNSDirector/PDMR Shareholding
1st Jul 20212:30 pmRNSHolding(s) in Company
22nd Jun 20218:36 amRNSDirectorate Change
22nd Jun 20217:00 amRNSFinal Results
29th Mar 20217:00 amRNSDirector Dealing
25th Mar 20217:00 amRNSDirector/PDMR Shareholding
15th Mar 20219:31 amRNSDirector/PDMR Shareholding
8th Mar 20217:00 amRNSTrading Update
18th Jan 20217:00 amRNSAcquisition
18th Dec 202011:05 amRNSDirector/PDMR Shareholding
24th Nov 20207:00 amRNSDirector/PDMR Shareholding
17th Nov 20202:06 pmRNSSecond Price Monitoring Extn
17th Nov 20202:00 pmRNSPrice Monitoring Extension
10th Nov 20207:00 amRNSHalf-year Report
5th Aug 20207:00 amRNSGrant of Awards under Long Term Incentive Plan
31st Jul 20207:00 amRNSDirector/PDMR Shareholding
30th Jul 20209:41 amRNSResult of AGM
29th Jul 20207:00 amRNSAGM Statement and Trading Update
27th Jul 20201:47 pmRNSDirector/PDMR Shareholding
27th Jul 20209:00 amRNSDirectorate Change
23rd Jun 20207:00 amRNSFinal Results
1st May 20207:00 amRNSYear end and COVID 19 trading update
24th Mar 20203:57 pmRNSCOVID 19 update
20th Feb 20209:45 amRNSDirector Dealing
14th Feb 202010:13 amRNSDirector Dealing
30th Jan 20208:55 amRNSDirector/PDMR Shareholding
24th Jan 20204:30 pmRNSDirector/PDMR Shareholding
21st Jan 20202:00 pmRNSHolding(s) in Company
13th Jan 202011:05 amRNSDirector/PDMR Shareholding
17th Dec 201912:24 pmRNSDirector/PDMR Shareholding
13th Dec 20197:00 amRNSDirectors' Dealings
29th Nov 201910:42 amRNSDirector/PDMR Shareholding
19th Nov 20197:00 amRNSHalf-year Report
24th Sep 20197:00 amRNSDirector/PDMR Shareholding
17th Sep 201911:20 amRNSDirector/PDMR Shareholding
12th Aug 20197:00 amRNSDirectors' Dealings
9th Aug 20197:00 amRNSNotification of Transaction of PDMR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.